Market Tracker

01/30 8:42am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

3.45
Data as of Jan 29
 +0.09 / +2.68%
Today’s Change
3.00
Today|||52-Week Range
19.11
-0.58%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.36
Today’s open3.35
Day’s range-- - --
Volume70,935
Average volume (3 months)306,269
Market cap$74.9M
Dividend yield--
Data as of 01/29/2015

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-8.45%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book69.11

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.15-1.89%
APPYVenaxis Inc-1.49-73.14%
TRILTrillium Therapeutic...+0.44+3.34%
TROVTrovagene Inc-0.02-0.34%
Data as of 01/29/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts